Clinical trial
Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients…
NCT00233532 · Abbott, Industry · Completed
Key facts
| NCT number | NCT00233532 |
|---|---|
| Title | Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients (TRAIL) |
| Official title | A Prospective, Open-Label Study to Evaluate the Effect of an Escalating Dose Regimen of Trandolapril on Blood Pressure in Treatment-Naïve and Concurrently Treated Hypertensive Patients (TRAIL) |
| Acronym | TRAIL |
| Lead sponsor | Abbott, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | Trandolapril |
| Enrollment | 2,000 |
| Start date | Mar 1, 2004 |
| Primary completion | Jun 1, 2005 |
| First posted | Oct 6, 2005 |
| Last update posted | Jul 22, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: